Skip to main content

Proof for prions?

Protein aggregates generated in a test tube were found to infect wild-type hamsters with a disease much like scrapie.

Written byBrendan Maher
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

Protein aggregates generated in a test tube were found to infect wild-type hamsters with a disease much like scrapie. Such a demonstration has, in the past, been called the gold standard of "proof" that infectious protein particles, or prions, free of nucleic acids, are the culprit in transmissible spongiform encephalopathies (TSEs). Study coauthor Claudio Soto says this demonstration,1 together with a paper published by Stanley Prusiner's group last summer,2 should allay most doubts. "There is really little room for skepticism."

Soto's group has been using a process that they call protein misfolding cyclic amplification (PMCA), which aids the conversion of the normal cellular proteins, PrPc, into the protease-resistant aggregates, PrPres, associated with TSE pathology. After seeding PrPc with PrPres, the solution is repeatedly incubated and sonicated to break up growing aggregates.

Crucially, however, the PrPres seed comes from infected hamster brain homogenate, while the normal PrPc comes from healthy hamster ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Related Topics

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
From Pilot to Practice: Advancing Regulatory Reliance

From Pilot to Precedent: A Year of Regulatory Innovation through PRISM and What it Means for Cloud Adoption in Regulatory Submissions

DNAnexus
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Improving Western Blot Analysis of Biofluid Samples

Improving Western Blot Analysis of Biofluid Samples

Bio-Rad
Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter

Products

Sino Biological Logo

Sino Biological Advances AI-Designed Molecule Validation with 4RISE™

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation